Medical News

RSS

Study to determine link between insulin glargine and cancer

Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications. However, these studies were unable to control for important factors such as obesity that may have driven the association.

15 Dec 2009

Enrolment for pivotal Phase II/III trial of C-Cure completed ahead of schedule

Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today that it has completed, two months ahead of schedule, enrolment in the first stage of its pivotal Phase II/III trial of C-Cure, a unique stem cell therapy for heart failure.

15 Dec 2009

Novo Nordisk initiates share repurchase programme

On 7 August 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

15 Dec 2009

Department of Health regulates home care agencies and registries in Pennsylvania

For the first time, home care agencies and registries must be licensed to operate in Pennsylvania and the home care industry will be regulated by the Department of Health.

15 Dec 2009

Beagle StepFit and BUDDY Tablet Caddy to be release along with VATA Brasil Collection

Muscle Flex Inc. (www.MuscleFlex.com) announced today that it will be releasing simultaneously the Beagle StepFit™ (www.BuyTheBeagle.com) and the BUDDY Tablet Caddy™ (www.GetTheBUDDY.com) along with the national release of the Muscle Flex VATA Brasil Sports and Active Wear Collection.

15 Dec 2009

Intensive medical therapy may benefit patients with asymptomatic plaque buildup

Intensive medical therapy, including aggressive control of blood pressure and cholesterol levels, for patients with asymptomatic plaque buildup in their carotid arteries (which supply blood to the brain) appears to be associated with reduced rates of cardiovascular events and reduced risk of microemboli (microscopic-sized blood clots) in the brain arteries, according to a report posted online today that will appear in the February 2010 print issue of Archives of Neurology, one of the JAMA/Archives journals.

15 Dec 2009

People with periodontal disease are at high risk for diabetes, survey finds

The study, led by Dr. Shiela Strauss, Associate Professor of Nursing and Co-Director of the Statistics and Data Management Core for NYU's Colleges of Dentistry and Nursing, examined data from 2,923 adult participants in the 2003-2004 National Health and Nutrition Examination Survey who had not been diagnosed with diabetes.

15 Dec 2009

Tendons control bone formation that leads to strong skeletal system

In all vertebrates, including humans, bones, muscles and tendons work together to give the skeleton its characteristic balance of stability and movement. Now, new research uncovers a previously unrecognized interaction between tendons, which connect muscles to bones, and the developing embryonic skeleton.

15 Dec 2009

Freie Universität professor receives ERC grant for bacterial biofilm formation study

Prof. Dr. Regine Hengge at the Department of Biology, Chemistry, and Pharmacy at Freie Universität Berlin has been awarded funding from the European Research Council (ERC) for her research project to investigate the formation of bacterial biofilms. Hengge will receive an ERC Advanced Investigator Grant in an amount of up to two million euros.

15 Dec 2009

Alvogen establishes operations in Asia and opens an office in Shanghai

Alvogen, Inc. (Alvogen), the U.S.-based pharmaceutical company, today announced that it has established operations in Asia and has opened an office in Shanghai, China that will lead efforts to commercialize the company’s products in the country.

15 Dec 2009

Supplements boost immune system and offer protection against seasonal flu

Accompanied by a chorus of coughs and sniffles, the winter season has arrived. "Protecting your health during this year's winter season should be a top priority for people," said Tom Tolworthy, CEO and Chief Health Enthusiast for The Vitamin Shoppe. "Many of our customers are being proactive in boosting their immune systems this time of year."

15 Dec 2009

PPI announces new Exotec Cubital Tunnel Splint

When staff from a leading orthopaedic group grew tired of struggling to apply the difficult to adjust and uncomfortable cubital tunnel splints available on the market, they enlisted Professional Products, Inc. (PPI) to develop a superior alternative. PPI, a leader and innovator in orthopaedic solutions for nearly five decades, responded with the revolutionary Exotec Cubital Tunnel Splint(TM) (cubitaltunnelsplint.com), which it announced today.

15 Dec 2009

RORalpha protein revealed as an essential regulator of inflammatory factors

How do the brain cells called astrocytes ensure the protection of neurons? By studying the protagonists in the protection and satisfactory functioning of neurons, scientists at the Laboratoire Neurobiologie des Processus Adaptatifs (CNRS/UPMC) have found a mechanism that clarifies the role of astrocytes.

15 Dec 2009

Lee Enterprises cancels health coverage for retirees

In an act of corporate greed, Lee Enterprises, owner of the St. Louis Post-Dispatch and other newspapers, is canceling company-paid health insurance for scores of retirees, the Newspaper Guild of St. Louis announced today. Retirees will protest outside the Post-Dispatch building, 900 North Tucker Boulevard, in downtown St. Louis, at 10 a.m. on Tuesday, Dec. 15.

15 Dec 2009

Mitrionics' Accelerated Computing Platform selected by QUT for accelerating algorithms

Mitrionics AB, the technology leader in FPGA-based hybrid computing, today announced that the Queensland University of Technology (QUT) High Performance Computing group has selected the Mitrion™ Accelerated Computing Platform to explore several projects designed to accelerate algorithms in different application areas.

15 Dec 2009

Florida doctor performs new, effective treatment for sinusitis

Local physician William Laskowski, MD has become the first doctor in Florida to perform an effective new treatment for sinusitis called FinESS® Sinus Treatment in an office setting. FinESS® (Entellus Medical, Maple Grove, MN) is a balloon sinuplasty option that is less-invasive than traditional sinus surgery and breaks the cycle of chronic or recurrent sinusitis with immediate relief and lasting results.

15 Dec 2009

Medline, 3M reach an amicable agreement over surgical hand cleaner allegations

Medline Industries, Inc., based in Mundelein, Illinois, and 3M Company, based in St. Paul, Minnesota, announced today that they have amicably reached an agreement resolving all claims between them based on allegations that each company made false claims in advertising promoting their respective surgical hand cleaners, Medline’s Sterillium® Rub and 3M’s Avagard™ Surgical Hand Antiseptic.

15 Dec 2009

Ethanol can worsen global health problems

Ethanol, often promoted as a clean-burning, renewable fuel that could help wean the nation from oil, would likely worsen health problems caused by ozone, compared with gasoline, especially in winter, according to a new study led by Stanford researchers.

15 Dec 2009

Retrospective study demonstrates new survival data for patients with myelofibrosis

A recent study, published in the December issue of Mayo Clinic Proceedings, demonstrates new survival data for the blood disorder myelofibrosis. This retrospective study is the largest ever conducted in young patients with primary myelofibrosis.

15 Dec 2009

Haemonetics alleges continued patent infringement by Fenwal, files a new lawsuit

Haemonetics Corporation announced today that it has filed a new legal action to stop Fenwal Inc.'s continued patent infringement resulting from Fenwal's just released red cell collection kits, using a modified separation chamber. Fenwal allegedly modified its separation chamber to circumvent Haemonetics' patent and the injunction entered by the Court prohibiting Fenwal's continued sale of infringing products after December 1, 2010.

15 Dec 2009